Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

DISEASE CHARACTERISTICS: * Diagnosis of one of the following cancers and undergoing high dose chemotherapy with autologous stem cell rescue (ASCR): * Metastatic breast cancer * Multiple myeloma * Hodgkin's disease * Recurrent or refractory low, intermediate, or high grade non-Hodgkin's lymphoma * Acute myelogenous leukemia beyond first remission * Acute lymphoblastic leukemia beyond first remission * Ovarian cancer * Refractory malignancy and measurable or evaluable disease (at time of ASCR) * Hormone receptor status: * Not specified * A new classification scheme for adult non-Hodgkin's lymphoma has been adopted by PDQ. The terminology of "indolent" or "aggressive" lymphoma will replace the former terminology of "low", "intermediate", or "high" grade lymphoma. However, this protocol uses the former terminology. PATIENT CHARACTERISTICS: Age: * Not specified Menopausal status: * Not specified Performance status: * Not specified Hematopoietic: * Not specified Hepatic: * Not specified Renal: * Not specified PRIOR CONCURRENT THERAPY: Biologic therapy: * See Disease Characteristics Chemotherapy: * See Disease Characteristics Endocrine therapy: * Not specified Radiotherapy: * Not specified Surgery: * Not specified